ANXA1 and infection: Given that AnxA1 reprograms the host immune response to terminate inflammation and in doing so does not interfere with the host’s ability to combat infections [28] recent studies have investigated the actions of peptides derived from the N-terminal portion of this protein as potential therapeutic leads [17, 29–31].